Invention Grant
- Patent Title: Bicyclic or tricyclic heterocyclic compound
-
Application No.: US14891845Application Date: 2015-04-22
-
Publication No.: US10065972B2Publication Date: 2018-09-04
- Inventor: Masahiro Okuyama , Kenji Fukunaga , Kenji Usui , Norimitsu Hayashi , Daisuke Iijima , Hideki Horiuchi , Noriaki Itagaki
- Applicant: MITSUBISHI TANABE PHARMA CORPORATION
- Applicant Address: JP Osaka-Shi
- Assignee: MITSUBISHI TANABE PHARMA CORPORATION
- Current Assignee: MITSUBISHI TANABE PHARMA CORPORATION
- Current Assignee Address: JP Osaka-Shi
- Agency: Birch, Stewart, Kolasch & Birch, LLP
- Priority: JP2014-089185 20140423
- International Application: PCT/JP2015/062165 WO 20150422
- International Announcement: WO2015/163339 WO 20151029
- Main IPC: C07D513/04
- IPC: C07D513/04 ; C07D471/04 ; C07D487/04 ; C07D513/14 ; C07D519/00 ; C07B59/00

Abstract:
The present invention provides a novel bicyclic or tricyclic heterocyclic compound represented by the formula (I) wherein ring A is an optionally substituted aromatic group, one of X1 and X2 is a carbon atom, and the other is a nitrogen atom, X3 is a nitrogen atom, or CR2, X4 is a nitrogen atom, or CR3, X5 is a sulfur atom, or —CH═CH—, Z1 is an oxygen atom, —C(R6)(R7)—, —NH—, —C(R6)(R7)—NH—, —NH—C(R6)(R7)—, —C(R6)(R7)—O—, —O—C(R6)(R7)—, or a single bond, one of Z2 and Z3 is CH and the other is a nitrogen atom, or both are nitrogen atoms, and other symbols are as defined in the DESCRIPTION, or a pharmacologically acceptable salt thereof.
Public/Granted literature
- US20160376289A1 NOVEL BICYCLIC OR TRICYCLIC HETEROCYCLIC COMPOUND Public/Granted day:2016-12-29
Information query